|
Micro-Sphere is active in proposing to customers the development
of formulations either on already known products or ex-novo development
in order to deliver a new proprietary formulation. Lipid-based formulations
are a key knowledge of the company (see lipo-technology section).
Moreover the company has also the capability to develop and test
formulations of dry powders for inhalation. The close collaboration
with Micro-Macinazione SA allows to produce micronized API powder
which combined with Micro-Sphere lactose for inhalation Lacto-Sphere®
are the key components for a formulation to be inhaled.
In addition the presence in the company of a spray drying equipment
is an other tool to produce powder to be inhaled. Of particular
interest is the possibility to have correct ratios between excipients
and API since both components are in solution before drying. Powder
can be tested by vertical or horizontal type of impactor.
Micro-Sphere can offer the monodose inhaler Turbospin®.
|